PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Forschergruppe Diabetes e. V., Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany. Oliver.Schnell@lrz.uni-muenchen.de.\', \'Sant Marti de Provençals Primary Care Centres, Barcelona, Spain.\', \'Karolinska University Hospital, Solna, Stockholm, Sweden.\', \'CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.\', \'Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy.\', \'Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.\', \'Cardiometabolic Center of Excellence, University of Missouri-Kansas City, Kansas, MO, USA.\', \'Universitätsklinikum Würzburg, Würzburg, Germany.\', \'Forschergruppe Diabetes e. V., Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12933-021-01254-1
?:hasPublicationType
?:journal
  • Cardiovascular diabetology
is ?:pmid of
?:pmid
?:pmid
  • 33789663
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.157
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all